about
Obesity status and sick leave: a systematic reviewHow good is the coverage and how accurate are exposure data in the Swedish Biologics Register (ARTIS)?Costs in Relation to Disability, Disease Activity, and Health-related Quality of Life in Rheumatoid Arthritis: Observational Data from Southern Sweden.Patients with rheumatoid arthritis treated with tumour necrosis factor antagonists increase their participation in the workforce: potential for significant long-term indirect cost gains (data from a population-based registry).Weight Loss and Heart Failure: A Nationwide Study of Gastric Bypass Surgery Versus Intensive Lifestyle Treatment.Ten years with biologics: to whom do data on effectiveness and safety apply?Effect of a very low energy diet on moderate and severe obstructive sleep apnoea in obese men: a randomised controlled trial.Effects of anti-obesity drugs, diet, and exercise on weight-loss maintenance after a very-low-calorie diet or low-calorie diet: a systematic review and meta-analysis of randomized controlled trialsExtraction of electronic health record data in a hospital setting: comparison of automatic and semi-automatic methods using anti-TNF therapy as model.Association of blood pressure in late adolescence with subsequent mortality: cohort study of Swedish male conscripts.Long-term changes in blood pressure following orlistat and sibutramine treatment: a meta-analysis.Longer term effects of very low energy diet on obstructive sleep apnoea in cohort derived from randomised controlled trial: prospective observational follow-up study.Drug survival on TNF inhibitors in patients with rheumatoid arthritis comparison of adalimumab, etanercept and infliximab.The prevalence of clinically diagnosed ankylosing spondylitis and its clinical manifestations: a nationwide register studyCost-effectiveness of infliximab versus conventional combination treatment in methotrexate-refractory early rheumatoid arthritis: 2-year results of the register-enriched randomised controlled SWEFOT trial.Weight loss and dropout during a commercial weight-loss program including a very-low-calorie diet, a low-calorie diet, or restricted normal food: observational cohort studyExercise capacity and muscle strength and risk of vascular disease and arrhythmia in 1.1 million young Swedish men: cohort study.Health-care costs over 15 years after bariatric surgery for patients with different baseline glucose status: results from the Swedish Obese Subjects study.4-Year Cost Trajectories in Real-World Patients Matched to the Metabolic Profiles of Trial Subjects Before/After Treatment with Phentermine-Topiramate.Combined effects of overweight and smoking in late adolescence on subsequent mortality: nationwide cohort study.Healthcare costs in chronic kidney disease and renal replacement therapy: a population-based cohort study in Sweden.Oral Contraceptive Use and Risk of Ulcerative Colitis Progression: A Nationwide StudyPerinatal outcomes after bariatric surgery: nationwide population based matched cohort study.Risk of symptomatic gallstones and cholecystectomy after a very-low-calorie diet or low-calorie diet in a commercial weight loss program: 1-year matched cohort study.Mortality in chronic kidney disease and renal replacement therapy: a population-based cohort study.Does cancer that occurs during or after anti-tumor necrosis factor therapy have a worse prognosis? A national assessment of overall and site-specific cancer survival in rheumatoid arthritis patients treated with biologic agents.Increased healthcare use up to 10 years among relapse-free Hodgkin lymphoma survivors in the era of intensified chemotherapy and limited radiotherapy.Does disease activity at start of biologic therapy influence work-loss in RA patients?Is there a sex bias in prescribing anti-tumour necrosis factor medications to patients with rheumatoid arthritis? A nation-wide cross-sectional study.Health care use during 20 years following bariatric surgery.Long-term incidence of microvascular disease after bariatric surgery or usual care in patients with obesity, stratified by baseline glycaemic status: a post-hoc analysis of participants from the Swedish Obese Subjects study.Effectiveness of Drugs in Routine Care: A Model for Sequential Monitoring of New Medicines Using Dronedarone as Example.Cost-effectiveness of first trimester non-invasive fetal RHD screening for targeted antenatal anti-D prophylaxis in RhD-negative pregnant women: a model-based analysis.Predictors of work disability after start of anti-TNF therapy in a national cohort of Swedish patients with rheumatoid arthritis: does early anti-TNF therapy bring patients back to work?Shift in the composition of obesity in young adult men in Sweden over a third of a century.Place of residence and obesity in 1,578,694 young Swedish men between 1969 and 2005.Infliximab Versus Conventional Combination Treatment and Seven-Year Work Loss in Early Rheumatoid Arthritis: Results of a Randomized Swedish Trial.Nationwide prevalence of rheumatoid arthritis and penetration of disease-modifying drugs in Sweden.Registers of the Swedish total population and their use in medical research.Change in Use of Sleep Medications After Gastric Bypass Surgery or Intensive Lifestyle Treatment in Adults with Obesity.
P50
Q22242401-8D3AA507-7C33-4B2D-A167-742045C9B4E2Q30868384-4C31D8BF-CFB0-4055-B410-E1F8C455D955Q31104809-ACA4F6CD-5C14-4506-856A-5B73B5BE92A7Q33453053-B1D621B3-B1D9-4F86-8B78-E8F224B78D0CQ33601449-85B23EA9-3142-4B6D-A581-590BCFF93868Q33749195-F352551B-4F43-4B2C-8E2C-42BDAF64BBB4Q34020411-D1ED552A-9974-44D0-AA55-DD31B9A946F4Q34381196-6E2140F5-ACA4-4EBF-A90F-EC75D7AE084FQ34572340-23F89982-97DB-4D90-8052-46BA7ADA49FFQ34591655-D36CAFFC-B015-446E-8B84-424BFAA1EA3DQ34615044-DC9201E3-8F73-47FD-A7DC-AD9CCC65D4B8Q35019549-81E58742-83B9-41C0-8DD4-B368AF0A01E3Q35048347-85103290-36DA-439C-A992-35694DC86CABQ35585070-F1C59418-DDE4-44C6-87C1-E1E7F09373D1Q35605415-48632A93-7CB3-4B53-9D7A-F329B2C3464AQ36317131-D5105C93-F389-4211-ADEA-6798C32FDA83Q36621337-F6D1EA7C-7873-4554-BE54-AE961B68D028Q36936333-33633072-BA92-4216-9E3B-57429EC36271Q36942815-991DD2C9-365A-416D-A856-8D49901F6D51Q37117189-D3A25D45-3EDE-48E9-8220-C47569CFCE93Q37356124-BB931FF9-5724-424B-BD8F-5AA331BAE77AQ37395980-0FDAA43F-4805-48B1-B462-894E9323A6B2Q37502140-A5D261B9-E73F-468E-9273-AA8BECABFECBQ37578963-BD372E66-462E-44AF-A7D4-D109AB2CB088Q37598037-5071BE07-EB06-49AB-8BCA-8351023A098AQ37838346-48C69D9B-C428-41A1-B49F-F386F91A683CQ38403661-CEE7E6C9-FB42-469B-8350-C88A02FAE89AQ38410704-4E325571-D5EC-404C-B73B-ED07CF65892AQ38433221-9084FE95-3764-414E-A49D-C99FCDD0D2DFQ38463944-97E38199-F56D-4426-9DE1-5DA40539D469Q38753187-902FEF64-5392-4F98-91F3-D799CD499773Q38754922-6C0625C1-870E-4129-906B-FBCCC5135880Q38932336-C7135FC4-EFED-438C-9C44-590FBD5F8450Q39028441-86DEF6C0-9CC3-484D-A404-9FF8FD842A33Q39826074-797EE0D8-17A2-4CFA-8402-047C26095CCFQ39831605-743BA50A-41DC-4BFA-AC76-60B83AF78630Q39888893-27B5D5B2-FA4A-4BB2-A043-E15ECBEE4776Q39962493-5CD755FC-941B-4464-AF3F-C5AA1F2528B5Q40105921-D2E5B423-9093-42B4-AD4C-D5ECF4798B11Q40141573-C4ABB9AC-AC64-45CF-B3F5-5E1FB4C1D295
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Martin Neovius
@ast
Martin Neovius
@en
Martin Neovius
@es
Martin Neovius
@nl
Martin Neovius
@sl
type
label
Martin Neovius
@ast
Martin Neovius
@en
Martin Neovius
@es
Martin Neovius
@nl
Martin Neovius
@sl
prefLabel
Martin Neovius
@ast
Martin Neovius
@en
Martin Neovius
@es
Martin Neovius
@nl
Martin Neovius
@sl
P106
P21
P31
P496
0000-0003-2300-3055